RenBio, Inc.
Antibody therapeutics platform using Make Your Own Technology™ for disease treatment
- Sector
- Biotech
- Headquarters
- Long Island City, NY
- Founded
- 2020
- Latest Form D
- $5.3M, Sep 2024
- Total capital
- $20M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $19.3M
- 2 Form D · last Sep 2024
- 26 months since last filing
- Federal contracts
- $749K
- 1 award · Health and Human S
- Rank in Biotech#208 of 4373
- Granted patents
- 0
- 9 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$5.3M
- Federal contractHealth and Human S · Renbio Inc. - AOI#25(FASTX) R&d For Myo Technology For Dna-based Delivery Of Anti-influenza Antibodies To Large Animals$749K
- Private capital raisedForm D · SEC · 1st filing$14M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Annelyn A. O'RourkeExecutive OfficerNamed in SEC Form D filings
- Chi-Chuan ChenDirectorNamed in SEC Form D filings
- David ChuDirectorNamed in SEC Form D filings
- Donald A. TangDirectorNamed in SEC Form D filings
- Jaap A. Goudsmit, M.D., Ph.D.DirectorNamed in SEC Form D filings
- Neal PadteExecutive Officer, DirectorNamed in SEC Form D filings
Show all 11 people
- Rachel A. Liberatore, Ph.D.Director, Executive OfficerNamed in SEC Form D filings
- Tamon TsengDirectorNamed in SEC Form D filings
- Walter A. Wang, Sr.DirectorNamed in SEC Form D filings
- Wan Feng TingDirectorNamed in SEC Form D filings
- Zhi A. Hong, Ph.D.DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 9- PendingDevice Related To Therapeutic Dna DeliveryUSPTOApplication 18862772
- PendingPlasmid Dna Constructs For Therapeutic Protein ExpressionUSPTOApplication 18862796
- PendingPlasmid Dna Constructs For Therapeutic Protein ExpressionUSPTOApplication PCTUS2023066688
Show all 9 patent records
- Device Related To Therapeutic Dna DeliveryNov 20, 2025 · Application 18862772Pending
- Plasmid Dna Constructs For Therapeutic Protein ExpressionSep 11, 2025 · Application 18862796Pending
- Plasmid Dna Constructs For Therapeutic Protein ExpressionApplication PCTUS2023066688Pending
- Device Related To Therapeutic Dna DeliveryApplication PCTUS2023066671Pending
- Compositions And Methods Related To Therapeutic Plasmid Dna ConstructsApplication 63338753Pending
- Device Related To Therapeutic Dna DeliveryApplication 63338774Pending
- Plasmid Dna Constructs For Peptide Hormone ExpressionApplication PCTUS2024055212Pending
- Plasmid Dna Constructs For Peptide Hormone ExpressionApplication 19585927Pending
- Plasmid Dna Constructs For Peptide Hormone ExpressionApplication 63597078Pending
Related companies, and why
- ATUX ISKAY GROUP LLCSimilar federal contract value in Biotech · $755K in contracts
- Rigel PharmaceuticalsSimilar federal contract value in Biotech · $750K in contracts
- GRYPHON BIO INCSimilar federal contract value in Biotech · $749K in contracts
- GEN1E LIFESCIENCES INC.Similar federal contract value in Biotech · $749K in contracts
- GALEN BIOTECHNOLOGIES, LLCSimilar federal contract value in Biotech · $727K in contracts
- KromaTiD, Inc.Similar federal contract value in Biotech · $726K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .